Legend Biotech Corp (NASDAQ:LEGN) reported its Q4 2025 earnings, showcasing robust growth with significant strides toward profitability. The company reported an EPS of $0.01, meeting the forecast, and ...
Legend Power Systems reported substantial financial improvements in its fiscal Q1 2026 earnings call, highlighting a 211% year-over-year revenue increase and significant gross margin expansion. The ...